PHOSMIDOSINE-B
Compound with spectra: 1 NMR
| SpectraBase Compound ID | G8UkCwTF6lJ |
|---|---|
| InChI | InChI=1S/C15H22N7O8P/c16-11-8-12(19-5-18-11)22(15(26)20-8)14-10(24)9(23)7(30-14)4-29-31(27,28)21-13(25)6-2-1-3-17-6/h5-7,9-10,14,17,23-24H,1-4H2,(H,20,26)(H2,16,18,19)(H2,21,25,27,28)/t6?,7-,9-,10-,14-/m0/s1 |
| InChIKey | SEHSCEYJWJDMSC-TZDMFSHLSA-N |
| Mol Weight | 459.36 g/mol |
| Molecular Formula | C15H22N7O8P |
| Exact Mass | 459.126748 g/mol |
| Enantiomer InChIKey | SEHSCEYJWJDMSC-JBJVTEQASA-N |
| Copyright | Copyright © 2016-2025 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | D2O |
6-N-ACETYL-5'-O-TERT.-BUTYLDIMETHYLSILYL-8-OXOADENOSINE
QUQHLBWIMPNBKJ-CFJVJASTSA-N
2-(9H-Fluoren-9-ylidene)-3,4-dihydro-6-(4-methoxyphenyl)-3,4-diphenyl-2H-1,3-thiazine
3-Oxo-2-(4-chlorophenyl)-N-(1,1,3,3-tetramethylbutyl)-1,2,3,4-tetrahydropyrazino[1,2-a]benzimidazole-1-carboxamide
(6RS,1'SR,4'RS)-(1'E,3'E)-Tricarbonyliron[2,3-didehydro-1-p-chlorohenyl-6-(.eta.4-1',4')-1',3'-pentadienylpiperdin-4-one]
bis(pentafluorobenzyl)-mebendazole
OBLONGIXANTHONE_3;1,5,6-TRIHYDROXY-3-METHOXY-8-(3-METHYL-2-BUTENYL)-4-(3,7-DIMETHYL-2,6-OCTADIENYL)-XANTHONE
1,1-Hydrazinedicarboxylic acid, 2-[[1,5-diphenyl-3-(phenylthioxomethyl)-1H-pyrazol-4-yl]phenylmethylene]-, dimethyl ester
1H-Pyrido[3,2,1-kl]phenothiazin-3-ol, 2,3-dihydro-2,2-bis(phenylthio)-
9-(3'-ACETYLTHIOMETHYL-6'-TERT.-BUTYLDIPHENYLSILYL-3',5'-DIDEOXY-BETA-ALLO-FURANOSYL)-N(6)-BENZOYLADENINE
| Title | Journal or Book | Year |
|---|---|---|
| Morphology Reversion Activity of Phosmidosine and Phosmidosine B, a Newly Isolated Derivative, on src Transformed NRK Cells. | The Journal of Antibiotics | 1996 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.